- Home
- INHD vs KZR Comparison
INHD vs KZR Comparison
Compare INHD & KZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INHD
- KZR
- Stock Information
- Founded
- INHD 2019
- KZR 2015
- Country
- INHD United States
- KZR United States
- Employees
- INHD N/A
- KZR N/A
- Industry
- INHD
- KZR Biotechnology: Pharmaceutical Preparations
- Sector
- INHD
- KZR Health Care
- Exchange
- INHD Nasdaq
- KZR Nasdaq
- Market Cap
- INHD 28.1M
- KZR 29.7M
- IPO Year
- INHD 2023
- KZR 2018
- Fundamental
- Price
- INHD $0.76
- KZR $6.22
- Analyst Decision
- INHD
- KZR Hold
- Analyst Count
- INHD 0
- KZR 4
- Target Price
- INHD N/A
- KZR $6.00
- AVG Volume (30 Days)
- INHD 390.0K
- KZR 83.3K
- Earning Date
- INHD 12-08-2025
- KZR 11-12-2025
- Dividend Yield
- INHD N/A
- KZR N/A
- EPS Growth
- INHD N/A
- KZR N/A
- EPS
- INHD N/A
- KZR N/A
- Revenue
- INHD $2,645,845.00
- KZR N/A
- Revenue This Year
- INHD N/A
- KZR N/A
- Revenue Next Year
- INHD N/A
- KZR N/A
- P/E Ratio
- INHD N/A
- KZR N/A
- Revenue Growth
- INHD 787.64
- KZR N/A
- 52 Week Low
- INHD $0.73
- KZR $3.53
- 52 Week High
- INHD $19.78
- KZR $7.65
- Technical
- Relative Strength Index (RSI)
- INHD 29.63
- KZR 69.90
- Support Level
- INHD $0.94
- KZR $6.07
- Resistance Level
- INHD $1.08
- KZR $6.23
- Average True Range (ATR)
- INHD 0.08
- KZR 0.15
- MACD
- INHD 0.04
- KZR -0.08
- Stochastic Oscillator
- INHD 5.06
- KZR 59.37
About INHD Inno Holdings Inc.
Inno Holdings Inc is a building technology company with a mission to transform the construction industry with its proprietary cold-formed steel-framing technology and other innovations. It is a manufacturer of cold-formed-steel members and prefabricated homes. It offers a full range of services required to transform raw materials into precise steel framing products and prefabricated homes. The company sells these finished products either to businesses or directly to customers. The finished products and cold-formed-steel members are used in a variety of building types, including residential, commercial, industrial and infrastructure.
About KZR Kezar Life Sciences Inc.
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.